iSpecimen Inc (ISPC)
0.2772
-0.02
(-6.07%)
USD |
NASDAQ |
Apr 24, 15:58
iSpecimen Cash from Operations (TTM): -5.808M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -5.808M |
September 30, 2023 | -6.36M |
June 30, 2023 | -6.983M |
March 31, 2023 | -7.267M |
December 31, 2022 | -5.818M |
September 30, 2022 | -6.930M |
June 30, 2022 | -10.75M |
Date | Value |
---|---|
March 31, 2022 | -11.92M |
December 31, 2021 | -10.67M |
September 30, 2021 | -9.373M |
June 30, 2021 | -3.613M |
March 31, 2021 | 0.0114M |
December 31, 2020 | -0.2884M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-11.92M
Minimum
Mar 2022
0.0114M
Maximum
Mar 2021
-6.598M
Average
-6.930M
Median
Sep 2022
Cash from Operations (TTM) Benchmarks
RadNet Inc | 220.86M |
DermTech Inc | -76.98M |
23andMe Holding Co | -183.50M |
Sera Prognostics Inc | -27.19M |
Progyny Inc | 188.81M |